SubluxationSHANCT06931600
Simulated vs Genuine Manual Chiropractic Adjustments
A study testing Chiropractic adjustment in people with Subluxation, run by Life University at 1 site in United States.
Trial summary
Our primary aim with this trial is to measure participant blinding following two simulated/sham or genuine/real high velocity, low amplitude (HVLA) manual chiropractic adjustments to assess if participants are able to identify their un-disclosed treatment group. Read more about this study
- Who is it for?
- Ages 18 to 60 yearsHealthy volunteers can take part
- Conditions the study is for
- Subluxation
- What is being tested?
- Chiropractic adjustment
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 60 participants
- Where
- 1 siteUnited States
- Study dates
- 5 May 2025to May 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- Healthy volunteers accepted
- Adult
- No history of stroke or transient ischemic attack or current symptoms including: Dizziness or vertigo; Tinnitus (ringing in the ears); Visual, sensory, or motor disturbances
- No new pattern headache complaint
- No recent whiplash injury (within 3 mo)
- No spinal fractures/dislocations
- No disc problems with radiating symptoms to the arms or legs
- No severe degenerative joint disease in the spine
- No connective tissue disorders
- No primary fibromyalgia
- No metabolic or metaplastic bone disease
- No diagnosed condition that causes fainting during postural changes, such as POTS or orthostatic hypotension
- No history of cervical, thoracic, or lumbar spine surgery
- No uncontrolled high blood pressure or vascular disease
- No current use of anticoagulant therapy
- No current use of short-acting benzodiazepines, including midazolam \& triazolam
- No change in medications in the past 6 weeks or intentions to change medications during the study
- Inability to walk unassisted on a treadmill
- No pacemakers or known heart conditions that influence the electrical or mechanical function of the heart, such as severe heart valve disease
- Not a DC or a DC student enrolled 4th quarter or above
- No present, self-reported pregnancy
- No chiropractic care in the 2 weeks prior to participation
- Did not participate in the feasibility study for this pilot (Perceptions and experiences following a single session of simulated or genuine high velocity, low amplitude (HVLA) manual chiropractic adjustments)
Trial locations and contacts
1 site in 1 country.
United States1 site
Dr. Sid E. Williams Center for Chiropractic Research
Marietta, Georgia, 30067
About this study
Official title: Blinding Integrity Following Multiple Sessions of Simulated or Genuine High Velocity, Low Amplitude (HVLA) Manual Chiropractic Adjustments: a Pilot Study
Our primary aim with this trial is to measure participant blinding following two simulated/sham or genuine/real high velocity, low amplitude (HVLA) manual chiropractic adjustments to assess if participants are able to identify their un-disclosed treatment group. Our secondary aims with this trial are to utilize electrocardiography (ECG), impedance cardiography (ICG), and gait analysis before either treatment session and after both treatment sessions to assess if there are any changes with the participants' measurements before and after a sham or genuine HVLA chiropractic treatment.
Read the detailed description
The primary aim of this trial is to assess blinding following simulated/sham or genuine/real high velocity, low amplitude (HVLA) manual chiropractic adjustments. Briefly, 60 eligible participants will be randomized (1:1 ratio) to receive two sessions of either simulated/sham or genuine/real chiropractic spinal adjustments with a 1 week washout between each treatment. The participants will be given a brief survey immediately following their first and second sessions, as well as immediately prior to the second session. This survey captures their perceptions and experiences regarding the intervention they received. The participants will also complete a pre- and post-electrocardiogram (ECG), impedance cardiography (ICG), and gait analysis. The participant will wear electrical diodes to assess ECG and ICG. Additional sensors will be placed on the participant to assess gait patterns while walking on a treadmill.
- Conditions
- Subluxation
- Being tested
- Sham adjustment, Chiropractic adjustment
- Keywords
- randomized, sham-controlled, chiropractic, blinding, gait analysis, impedance cardiography, movement parameters, electrocardiography, autonomic nervous system, Heart Rate Variability
- Medical subject headings
- Joint Dislocations
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Sham adjustmentProcedure or surgery
Two manual high velocity, low amplitude (HVLA) simulated/sham chiropractic interventions in the cervical, thoracic, and/or lumbopelvic regions
Chiropractic adjustmentProcedure or surgery
Two manual high velocity, low amplitude (HVLA) genuine/real chiropractic interventions in the cervical, thoracic, and/or lumbopelvic regions
| Study group | Role | What they receive |
|---|---|---|
| Simulated/sham | Sham comparator | 30 individuals receiving simulated/sham chiropractic interventions Receives: Procedure: Sham adjustment |
| Genuine/real | Experimental | 30 individuals receiving genuine/real chiropractic interventions Receives: Procedure: Chiropractic adjustment |
What is being measured
The primary outcome is the main question the study is designed to answer.
Participant blinding
The blinding index is scaled to an internal of -1 to +1, +1 being complete lack of blinding, 0 being consistent with perfect blinding, -1 indicating opposite guessing which may be related to unblinding.
Measured: Immediately post-session 1 (day 1)
Participant blinding
The blinding index is scaled to an internal of -1 to +1, +1 being complete lack of blinding, 0 being consistent with perfect blinding, -1 indicating opposite guessing which may be related to unblinding.
Measured: Immediately pre-session 2 (day 2)
Participant blinding
The blinding index is scaled to an internal of -1 to +1, +1 being complete lack of blinding, 0 being consistent with perfect blinding, -1 indicating opposite guessing which may be related to unblinding.
Measured: Immediately post-session 2 (day 2)
Secondary outcomes (12)
High-frequency Heart Rate Variability (HF-HRV)
3 sensors on torso. HF-HRV indexes fluctuations in the heart period that occur within the 0.12 to 0.5 Hz frequency range
Measured: baseline
High-frequency Heart Rate Variability (HF-HRV)
3 sensors on torso. HF-HRV indexes fluctuations in the heart period that occur within the 0.12 to 0.5 Hz frequency range.
Measured: post-session 2 (day 2)
Pre-ejection period (PEP)
3 ECG sensors on the torso + 4 ICG sensors (2 sensors on chest and 2 sensors on back). The PEP is the time interval between the electrical depolarization of the heart (Q-wave on ECG) and the beginning of blood ejection from the heart (B-point on ICG).
Measured: baseline
Pre-ejection period (PEP)
3 ECG sensors on the torso + 4 ICG sensors (2 sensors on chest and 2 sensors on back). The PEP is the time interval between the electrical depolarization of the heart (Q-wave on ECG) and the beginning of blood ejection from the heart (B-point on ICG).
Measured: post-session 2 (day 2)
The speed of the participants will be assessed at baseline as part of the gait analysis.
16 inertial measurement unit (IMU) sensors (noraxon) and treadmill output measurements
Measured: baseline
The speed of the participants will be assessed again at post-session 2 as part of the gait analysis.
16 inertial measurement unit (IMU) sensors (noraxon) and treadmill output measurements
Measured: post-session 2 (day 2)
Force measurements generated during walking will be assessed at baseline as part of the gait analysis.
16 inertial measurement unit (IMU) sensors (noraxon) and treadmill output measurements
Measured: baseline
Force measurements generated during walking will be assessed again at post-session 2 as part of the gait analysis.
16 inertial measurement unit (IMU) sensors (noraxon) and treadmill output measurements
Measured: post-session 2 (day 2)
Gait symmetry will be assessed at baseline as part of the gait analysis.
16 inertial measurement unit (IMU) sensors (noraxon)
Measured: baseline
Gait symmetry will be assessed again at post-session 2 as part of the gait analysis.
16 inertial measurement unit (IMU) sensors (noraxon)
Measured: post-session 2 (day 2)
Root Mean Square of Successive Differences (RMSSD)
3 sensors on torso. RMSSD is a measure of heart rate variability (HRV) that focuses on short-term beat-to-beat changes in the heart period.
Measured: baseline
Root Mean Square of Successive Differences (RMSSD)
3 sensors on torso. RMSSD is a measure of heart rate variability (HRV) that focuses on short-term beat-to-beat changes in the heart period.
Measured: post-session 2 (day 2)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Apr 2025
- Study start5 May 2025
- Primary completionApr 2026 (estimated)
- Study completionMay 2026 (estimated)
Why it stopped: Funding
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for SubluxationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- randomized, sham-controlled, pilot study
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Life University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Tyson Perez, DC, PhD, Life University
- Investigators
- Tyson Perez, DC, PhD, Principal investigator, Life University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06931600
- Sponsor's protocol ID
- I-0032
- Acronym
- SHA
- Status last verified
- Mar 2026
- First submitted
- 28 Mar 2025
- Last updated
- 30 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Sliwka M, Perez T, Qazi A, Sullivan S. Spinal Manipulative Therapy on a Healthy Population: Protocol for a Randomized Blinding Feasibility Trial. JMIR Res Protoc. 2026 Mar 27;15:e85956. doi: 10.2196/85956.
PubMed 41894654
Study at a glance
From the registry record, last updated by the sponsor on 30 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Blinding Integrity Following Multiple Sessions of Simulated or Genuine High Velocity, Low Amplitude (HVLA) Manual Chiropractic Adjustments: a Pilot Study
- ClinicalTrials.gov ID
- NCT06931600
- Acronym / sponsor ID
- SHA / I-0032
- Conditions
- Subluxation
- Keywords
- randomized, sham-controlled, chiropractic, blinding, gait analysis, impedance cardiography, movement parameters, electrocardiography
- Study type
- Interventional
- Recruitment status
- SuspendedReason stopped: Funding
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Life UniversityUniversity, hospital or other
- Study start
- 5 May 2025 (actual)
- Primary completion
- Apr 2026 (estimated)
- Study completion
- May 2026 (estimated)
- First posted
- 17 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Our primary aim with this trial is to measure participant blinding following two simulated/sham or genuine/real high velocity, low amplitude (HVLA) manual chiropractic adjustments to assess if participants are able to identify their un-disclosed treatment group. Our secondary aims with this trial are to utilize electrocardiography (ECG), impedance cardiography (ICG), and gait analysis before either treatment session and after both treatment sessions to assess if there are any changes with the participants' measurements before and after a sham or genuine HVLA chiropractic treatment.
Detailed description
The primary aim of this trial is to assess blinding following simulated/sham or genuine/real high velocity, low amplitude (HVLA) manual chiropractic adjustments. Briefly, 60 eligible participants will be randomized (1:1 ratio) to receive two sessions of either simulated/sham or genuine/real chiropractic spinal adjustments with a 1 week washout between each treatment. The participants will be given a brief survey immediately following their first and second sessions, as well as immediately prior to the second session. This survey captures their perceptions and experiences regarding the intervention they received. The participants will also complete a pre- and post-electrocardiogram (ECG), impedance cardiography (ICG), and gait analysis. The participant will wear electrical diodes to assess ECG and ICG. Additional sensors will be placed on the participant to assess gait patterns while walking on a treadmill.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
- Model description
- randomized, sham-controlled, pilot study
| Arm | Type | Receives |
|---|---|---|
| Simulated/sham | Sham comparator | Procedure: Sham adjustment30 individuals receiving simulated/sham chiropractic interventions |
| Genuine/real | Experimental | Procedure: Chiropractic adjustment30 individuals receiving genuine/real chiropractic interventions |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Sham adjustmentTwo manual high velocity, low amplitude (HVLA) simulated/sham chiropractic interventions in the cervical, thoracic, and/or lumbopelvic regions | Procedure or surgery | Simulated/sham |
| Chiropractic adjustmentTwo manual high velocity, low amplitude (HVLA) genuine/real chiropractic interventions in the cervical, thoracic, and/or lumbopelvic regions | Procedure or surgery | Genuine/real |
Primary outcome
Participant blinding
Time frame: Immediately post-session 1 (day 1)
The blinding index is scaled to an internal of -1 to +1, +1 being complete lack of blinding, 0 being consistent with perfect blinding, -1 indicating opposite guessing which may be related to unblinding.
Participant blinding
Time frame: Immediately pre-session 2 (day 2)
The blinding index is scaled to an internal of -1 to +1, +1 being complete lack of blinding, 0 being consistent with perfect blinding, -1 indicating opposite guessing which may be related to unblinding.
Participant blinding
Time frame: Immediately post-session 2 (day 2)
The blinding index is scaled to an internal of -1 to +1, +1 being complete lack of blinding, 0 being consistent with perfect blinding, -1 indicating opposite guessing which may be related to unblinding.
12 secondary outcomes
High-frequency Heart Rate Variability (HF-HRV)
Time frame: baseline
High-frequency Heart Rate Variability (HF-HRV)
Time frame: post-session 2 (day 2)
Pre-ejection period (PEP)
Time frame: baseline
Pre-ejection period (PEP)
Time frame: post-session 2 (day 2)
The speed of the participants will be assessed at baseline as part of the gait analysis.
Time frame: baseline
The speed of the participants will be assessed again at post-session 2 as part of the gait analysis.
Time frame: post-session 2 (day 2)
Force measurements generated during walking will be assessed at baseline as part of the gait analysis.
Time frame: baseline
Force measurements generated during walking will be assessed again at post-session 2 as part of the gait analysis.
Time frame: post-session 2 (day 2)
Gait symmetry will be assessed at baseline as part of the gait analysis.
Time frame: baseline
Gait symmetry will be assessed again at post-session 2 as part of the gait analysis.
Time frame: post-session 2 (day 2)
Root Mean Square of Successive Differences (RMSSD)
Time frame: baseline
Root Mean Square of Successive Differences (RMSSD)
Time frame: post-session 2 (day 2)
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Mar 2026.
- Derived from this study: PubMed 41894654Sliwka M, Perez T, Qazi A, Sullivan S. Spinal Manipulative Therapy on a Healthy Population: Protocol for a Randomized Blinding Feasibility Trial. JMIR Res Protoc. 2026 Mar 27;15:e85956. doi: 10.2196/85956.
- Individual participant dataSharing planned: No
Related trials for Subluxation
Not yet recruitingPhase 1/2
Regenerative Medicine for Joint Hypermobility and Instability
Ehlers-Danlos Syndrome Hypermobility Type (hEDS), Ehlers-Danlos Syndrome (EDS)
Not yet recruiting
Assessment of Posterior Subluxation of the Humeral Head Using Biplanar Imaging in the Upright Position in Patients Scheduled for Total Shoulder Arthroplasty
Shoulder Arthroplasty
Recruiting
Validation of an Upper Extremity Physical Performance Test Battery in Patients After Shoulder Dislocation
Return to Sport, Shoulder Dislocation or Subluxation
Not yet recruitingObservational study
Investigation of the Relationship Between Shoulder Alpha Angle and Humeral Head Displacement Percentage Measured by Ultrasonography in Neonatal Brachial Plexus Palsy Infants With Clinical Parameters
Glenohumeral Subluxation, Neonatal Brachial Plexus Palsy
Active, not recruitingObservational study
Multicenter Study on the Use of Intraoperative OCT in the Diagnosis and Management of Lens Diseases
Lens Diseases, Cataract
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Tyson Perez, DC, PhD principal investigator
Life University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Chiropractic adjustment in people with Subluxation, run by Life University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: paused, as of the sponsor's last update on 30 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Participant blinding (time frame: Immediately post-session 1 (day 1)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06931600, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2026.